Incyte Q2 Adjusted EPS $0.99 Beats $0.87 Estimate, Sales $954.61M Beat $920.18M Estimate
Portfolio Pulse from Benzinga Newsdesk
Incyte (NASDAQ:INCY) reported Q2 earnings of $0.99 per share, beating the analyst consensus estimate of $0.87 by 13.79%. This is a 1.98% decrease from the same period last year. The company also reported quarterly sales of $954.61 million, beating the analyst consensus estimate of $920.18 million by 3.74%. This is a 4.74% increase from the same period last year.
August 01, 2023 | 11:08 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Incyte's Q2 earnings and sales exceeded analyst estimates, which could positively impact the stock in the short term. However, the slight decrease in earnings from last year could temper this impact.
Incyte's Q2 earnings and sales beat analyst estimates, which is generally a positive signal for the stock. However, the slight decrease in earnings from the same period last year could be a cause for concern for some investors, potentially tempering the positive impact of the earnings beat.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100